Clinical Trials Browser

Phase 2 × INDUSTRY × pyrotinib × Clear all

NCT02834936 2025-08-28

A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation

Phase 2 Completed

Non Small Cell Lung